← Eichor
Study identifier: NCT06810622 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

Condition: Kidney Diseases · Chronic Kidney Diseases  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants448
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The overarching goal of this project is to refine and adapt previous work on the NAVIGATE-Kidney project for individuals with CKD. The investigators hypothesize that the multilevel NAVIGATE-Kidney program intervention will reduce the rate of central venous catheter use at KRT start (primary outcome), increase the rate of optimal KRT starts (secondary outcome), increase patient activation, and reduce decisional conflict (patient-centered outcomes) for individuals with advanced CKD. The project will have four (4) aims.

This description comes directly from the study's public registry record.

Talk to the study team

Lilia Cervantes, MD  ·  3036418009  ·  lilia.cervantes@cuanschutz.edu

Sandra Hernandez, MPH  ·  SANDRA.GARCIA-HERNANDEZ@CUANSCHUTZ.EDU

Always discuss trial participation with your own doctor first.

Locations (2)

Denver Health and Hospital AuthorityDenver, Colorado, United StatesRecruiting
University of New Mexico Health Science CenterAlbuquerque, New Mexico, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06810622